[Operative efficacy of 13 malignant uterine tumors after Cf-252 intracavitary irradiation]

Zhonghua Zhong Liu Za Zhi. 2020 Oct 23;42(10):882-884. doi: 10.3760/cma.j.cn112152-20190903-00570.
[Article in Chinese]

Abstract

Objective: To investigate the surgical therapeutic efficacy of uterine tumors patients underwent Cf-252 neutron intra-cavity and external radiotherapy, and evaluate the application value of Cf-252 neutron radiotherapy. Methods: Thirteen cases of uterine tumor with local suspicious lesions or poor prognostic factors after CF-252 neutron intracavity and external radiotherapy were treated with surgery. Among them, 12 cases underwent extrafascial hysterectomy, 1 case underwent extensive hysterectomy and lymphadenectomy. The postoperative pathology and follow-up results were used to evaluate the efficacy. Results: Nine cases showed severe response to radiotherapy in postoperative cervical pathological tissues without residual tumor, and survived for more than 3-14 years, the median survival time was 8 years. All of 4 cases with residual tumor died within 1 year. Delayed healing of vaginal wounds occurred in 3 of the 12 cases. Conclusions: Cf-252 is a good brachytherapy source. The cervical tissue shows severe response to radiotherapy and prolonged healing time of vaginal wound is observed in some cases after CF-252 radiotherapy. To those uterine tumor patients with local suspicious lesions or poor prognostic factors after CF-252 neutron intracavity and external radiotherapy, extrafascial hysterectomy is a safe and feasible treatment method.

目的: 分析子宫肿瘤患者接受锎-252中子腔内和体外放疗后手术结果,评估锎-252中子治疗的价值。 方法: 对13例接受锎-252中子腔内放疗及体外照射后、局部可疑肿瘤未控制或具有预后不良因素的子宫肿瘤患者,进行手术治疗。12例行筋膜外子宫切除,1例行子宫广泛切除+淋巴清扫。依据术后病理和随访结果进行疗效评价。 结果: 9例患者术后宫颈病理组织呈重度放疗反应,无肿瘤残存,生存时间为3~14年,中位生存时间8年;4例术后病理有肿瘤残存,均在1年内死亡。12例患者中,3例阴道伤口延迟愈合。 结论: 锎-252为较好的近距离放射源,使用锎-252放疗后宫颈组织反应较重,部分患者阴道伤口愈合时间延长。对于接受锎-252中子腔内放疗及体外照射后、局部仍存在可疑肿瘤未控制或具有预后不良因素的子宫肿瘤患者,筋膜外子宫切除术是安全可行的治疗方法。.

Keywords: Cf-252 brachytherapy; Endometrial neoplasms; Surgery; Uterine neoplasms.

MeSH terms

  • Brachytherapy*
  • Californium / therapeutic use*
  • Female
  • Humans
  • Hysterectomy
  • Uterine Neoplasms* / radiotherapy
  • Uterine Neoplasms* / surgery

Substances

  • Californium
  • Californium-252